| London-based biotech company FabRx is using additive manufacturing technology to develop 3D printed tablets called 'Printlets'. The company relies on selective laser sintering technology developed by Swiss additive company Sintratec. Selective laser sintering (often called SLS) It is a 3D printing technology that relies on a laser system to sinter a bed of powder material, usually a polymer-based material such as nylon.  According to reports, FabRx has invested in the second Sintratec Suite SLS 3D printer, which is ideally suited for producing functional prototypes thanks to its high resolution and free build capabilities. The 3D printer launched in 2014 launched a very successful crowdfunding campaign. Activities (Sintratec has raised more than US$200,000 in funds to bring SLS 3D printers to market). FabRx has discovered the use of Sintratec Kit 3D printers in the pursuit of the development of 3D printing medicine. Because the printer model uses powder-based materials, Technology companies have been able to introduce drug compounds into powders and print them in various shapes, sizes, colors, and textures. Fabrizio Fina of FabRx said: “The Sintratec Kit has provided us with a completely new approach to the development of new drugs. 'After obtaining surprising results, we recently purchased another Sintratec kit!' The company stated that the SLS 3D printer is well suited for tablet PC printing applications because it allows users to fine-tune and monitor settings such as laser speed and material temperature. When using fragile pharmaceutical compounds, maintaining a certain temperature ensures the quality of the drug And effectiveness is crucial. FabRx is using its two Sintratec Kit 3D printers to develop 3D printing 'Printlets', just one of the company's AM-related biotechnology projects. In December last year, the company caught our attention and turned the Magic Candy Factory candy 3D printer into a personalized medicine for children. The 3D printer that is usually used to make marshmallow candy was reused in 3D printing of medicinal confectionery candy. A kid who even hates the most flavorful liquid drugs, I think a soft candy candy drug can better cure the disease.)
As a derivative of the University College London Research Group, the ultimate goal of FabRx is to develop more enjoyable drugs and treatments that are more appealing to specific groups such as children. Alvaro Goyanes, FabRx Development Director, said: 'We want to use 3D printing. To change the face of drug production and provide better access to drugs, especially for children. Source: China 3D Printing Network |
 |
|